Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France
- 1 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 16 (1) , 26-35
- https://doi.org/10.1097/01.cej.0000228399.30235.bc
Abstract
A combined breast, cervical and colorectal cancer screening programme was set up in 1990 in Isère, for women aged 50–69 years (target population 100 000) comprising an initial medical visit. The programme was evaluated in 1997. The evaluation covered uptake results, sensitivity, specificity, two opinion surveys among 1025 physicians and 400 women to measure the impact, and three surveys regarding radiologists', gastroenterologists' and pathologists' attitudes. Sensitivity and specificity rates were 74 and 87% for breast, 83 and 99% for cervical and 43 and 97% for colorectal screening. The number of cervical smears completed by women aged 60–69 years doubled with the programme. Acceptability of the faecal occult blood test was 88%. Eighty percent of physicians were in favour of the programme but 67% said that they often prescribed outside the programme. Overall, 71% of the interviewed women said they had had a breast screen, 69% a Pap smear and 53% a faecal occult blood test when only 25–35% of the target population was actually recorded in the programme. This programme increased the uptake of women not previously screened both within and outside the programme. It showed discrepancies between beliefs and practices of physicians. Protocol changes were implemented after this evaluation.Keywords
This publication has 18 references indexed in Scilit:
- Fecal Occult Blood Test Screening for Colorectal CancerGastrointestinal Endoscopy Clinics of North America, 2002
- Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screeningBritish Journal of Cancer, 2001
- Deprived areas and attendance to screening of cervix uteri cancer in a French region.Cancer Causes & Control, 2000
- Is screening for breast cancer with mammography justifiable?The Lancet, 2000
- Analysis and classification of interval cancers in a French breast cancer screening programme (départment of Isère)European Journal Of Cancer Prevention, 1999
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.Journal of Epidemiology and Community Health, 1996
- Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervixBritish Journal of Cancer, 1995
- Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.BMJ, 1988